Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma.

@article{Liam2006EpidermalGF,
  title={Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma.},
  author={Chong-Kin Liam and Yong-Kek Pang and C H Leow},
  journal={Respirology},
  year={2006},
  volume={11 3},
  pages={287-91}
}
OBJECTIVE To describe the efficacy of monotherapy with the epidermal growth factor receptor-tyrosine kinase inhibitor, gefitinib in patients with locally advanced and metastatic primary lung adenocarcinoma. METHODS A retrospective analysis was undertaken of patients who had locally advanced or metastatic lung adenocarcinoma treated with gefitinib 250 mg orally once daily until disease progression. All patients had either been previously treated with systemic cytotoxic chemotherapy and/or… CONTINUE READING